Inhaled Corticosteroids and LABAs - Removal of the FDA's Boxed Warning
- PMID: 29949485
- DOI: 10.1056/NEJMp1716858
Inhaled Corticosteroids and LABAs - Removal of the FDA's Boxed Warning
Similar articles
-
Use of long-acting beta-agonists and inhaled steroids in asthma: meta-analysis of observational studies.J Asthma. 2010 May;47(4):439-46. doi: 10.3109/02770901003605340. J Asthma. 2010. PMID: 20528600
-
FDA panel: ban 2 popular asthma drugs.JAMA. 2009 Jan 28;301(4):365-6. doi: 10.1001/jama.2008.991. JAMA. 2009. PMID: 19176431 No abstract available.
-
Budesonide/formoterol maintenance plus reliever therapy: a new strategy in pediatric asthma.Chest. 2006 Dec;130(6):1733-43. doi: 10.1378/chest.130.6.1733. Chest. 2006. PMID: 17166990 Clinical Trial.
-
An update on the safety of long-acting beta-agonists in asthma patients using inhaled corticosteroids.Expert Opin Drug Saf. 2010 May;9(3):407-19. doi: 10.1517/14740330903535852. Expert Opin Drug Saf. 2010. PMID: 20408768 Review.
-
[Interaction between inhaled corticosteroids and long-acting beta-2-agonists].Dtsch Med Wochenschr. 2009 Dec;134 Suppl 10:S386-9. doi: 10.1055/s-0029-1243047. Epub 2009 Nov 25. Dtsch Med Wochenschr. 2009. PMID: 19941242 Review. German. No abstract available.
Cited by
-
Inhaled drug delivery for the targeted treatment of asthma.Adv Drug Deliv Rev. 2023 Jul;198:114858. doi: 10.1016/j.addr.2023.114858. Epub 2023 May 12. Adv Drug Deliv Rev. 2023. PMID: 37178928 Free PMC article. Review.
-
Pediatric asthma: Principles and treatment.Allergy Asthma Proc. 2019 Nov 1;40(6):389-392. doi: 10.2500/aap.2019.40.4254. Allergy Asthma Proc. 2019. PMID: 31690377 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical